Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.
about
Benchtop technologies for circulating tumor cells separation based on biophysical properties.Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and BackStem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerMicroscale magnetic field modulation for enhanced capture and distribution of rare circulating tumor cellsPrognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohortRational Design of Materials Interface for Efficient Capture of Circulating Tumor Cells.High resolution digital autoradiographic and dosimetric analysis of heterogeneous radioactivity distribution in xenografted prostate tumors.DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment.Clog-free cell filtration using resettable cell traps.Circulating tumor cells in prostate cancer: Precision diagnosis and therapyNumerical simulation of a single cell passing through a narrow slit.Monolithic Chip for High-throughput Blood Cell Depletion to Sort Rare Circulating Tumor Cells.Mechanical Contact Characteristics of PC3 Human Prostate Cancer Cells on Complex-Shaped Silicon Micropillars.Automated electrorotation shows electrokinetic separation of pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and EMT.Microfluidic Separation of Circulating Tumor Cells Based on Size and Deformability.Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from Blood.On-chip cell labelling and washing by capture and release using microfluidic trap arrays.Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device.Effects of diffusion time on non-Gaussian diffusion and intravoxel incoherent motion (IVIM) MRI parameters in breast cancer and hepatocellular carcinoma xenograft models.Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.Third-harmonic generation imaging of breast tissue biopsies.Magnetic separation of acoustically focused cancer cells from blood for magnetographic templating and analysis.Continuous Flow Deformability-Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets.Efficient microfluidic negative enrichment of circulating tumor cells in blood using roughened PDMS.Microstructure Characterization of Bone Metastases from Prostate Cancer with Diffusion MRI: Preliminary Findings.Particle Shape Influences Settling and Sorting Behavior in Microfluidic Domains.Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology.Detection, manipulation and post processing of circulating tumor cells using optical techniques
P2860
Q27028049-AE76E97E-882F-484A-B039-31896EE7DE02Q28070333-96409472-9792-4279-ABBD-69A523AB98E5Q28079205-28F6A619-BDC6-44BE-BB2B-625A1B1F4F8EQ34465467-026AFBA1-7AF7-42FB-88E0-733F27D53D1AQ36070763-3B845F0D-3CCE-4A84-A74D-003D0AEB015BQ37422977-522A450E-1429-4192-AA68-7A32EB68A145Q38728044-31C5D3D0-8874-4ADF-8ECA-2A3BC7AB21D4Q38774228-51D31FA2-1C84-4B58-9AC1-15A9F618BD14Q38813934-E06E8EDA-DCA0-4B8D-A74A-77650B85A986Q39006769-52364655-F58D-4C11-9F63-6D6E3D80AE09Q41142322-DCFDC37B-90E2-4E82-8E8C-93C92D26C8D2Q41471183-3D9B98EA-7BE1-46AA-8F11-82651546193DQ41537748-43F210E6-40CD-4663-98D1-AB35B2A9E873Q41574989-3D55F426-0813-414E-AE10-7CBEE8D1B4C8Q44814353-C5ADAFE1-335D-4B3C-BD36-B5E7D0D5A054Q47193399-CB6389F7-0793-4F85-AC34-25D119751315Q47396181-9FE48DBC-4C18-4A83-AAFC-A413051BD68EQ47442918-16D4CA58-B3EC-4B8C-9365-BDFAD2C3B211Q48093681-48B498FB-ACE5-4699-B7CC-C6673C493CACQ48162044-0D4FC944-42ED-4D3E-BFEA-2A51FEB0C55FQ49796329-FE468AF6-5B91-4611-AE1A-42755DD00623Q50638003-59D177F4-B2C4-4FA5-8DF7-B94DDB064DF1Q51143184-C40180B9-3E08-41F9-8B9A-B877FC591019Q51492172-13FF9423-A89E-4218-BB38-5EBA8C298B19Q51495698-EECC3E10-A8FE-4C19-9105-8F35F6FD474DQ55167689-08567D02-F250-42AE-96FC-FDC8DED33D66Q55253293-6C83EE8A-D14E-430B-A791-29DA550F4703Q55394255-210A5503-6B36-41CE-8558-3DD1B53E7D2AQ57722872-677AAFD7-9AFF-46ED-A2C4-0E57AB710FE3
P2860
Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Morphological differences betw ...... ultured prostate cancer cells.
@en
Morphological differences betw ...... ultured prostate cancer cells.
@nl
type
label
Morphological differences betw ...... ultured prostate cancer cells.
@en
Morphological differences betw ...... ultured prostate cancer cells.
@nl
prefLabel
Morphological differences betw ...... ultured prostate cancer cells.
@en
Morphological differences betw ...... ultured prostate cancer cells.
@nl
P2093
P2860
P1433
P1476
Morphological differences betw ...... ultured prostate cancer cells.
@en
P2093
Hongshen Ma
Jenny Bazov
Peter C Black
Richard R Ang
Simon P Duffy
Sunyoung Park
P2860
P304
P356
10.1371/JOURNAL.PONE.0085264
P407
P577
2014-01-08T00:00:00Z